Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681) - R6 - Effective August 1, 2024

Date Posted: August 1, 2024

This coverage article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: August 1, 2024

Summary of Article Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted K63.5. Added C23, C24.1, C24.8, C48.0, C53.8, C67.0, C67.1, C67.2, C67.3, C67.4, C67.5, C67.6, C67.7, C67.8, C67.9, C79.11, D00.2, D01.0, D01.1, D01.2, D01.40, D01.49, D01.5, D01.7, D05.00, D05.01, D05.02, D05.10, D05.80, D05.81, D05.82, D05.90, D05.91, D05.92, D06.0, D06.1, D07.0, D07.5, D09.3, D09.8, Z85.51, Z86.001, Z86.002, and Z86.004.

Visit the Noridian Billing and Coding Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )